Table 4.
Subgroup analyses on study eye sizes.
| Eye sizes (≧100 versus < 100) | Studies | Eyes | OR or MD (95%CI) | P | I2 |
| Postoperative UCVA of 20/20 or better | 8 | 1397 | OR 1.09 (0.62, 1.92) | .763 | 0.0% |
| ≧100 | 4 | 1090 | OR 1.16 (0.55, 2.44) | .697 | 0.0% |
| <100 | 4 | 307 | OR 1.00 (0.42, 2.38) | .991 | 0.0% |
| Postoperative UCVA | 7 | 1645 | MD 0.04 (0.01, 0.07) | .012 | 76.9% |
| ≧100 | 5 | 1543 | MD 0.05 (0.01, 0.08) | .006 | 82.8% |
| <100 | 2 | 102 | MD −0.01 (−0.09, 0.07) | .839 | 0.0% |
| Preoperative Q-value | 11 | 1605 | MD −0.00 (−0.02, 0.02) | .922 | 68.0% |
| ≧100 | 6 | 1242 | MD −0.01 (−0.03, 0.02) | .678 | 82.9% |
| <100 | 5 | 363 | MD 0.01 (−0.02, 0.03) | .547 | 0.0% |
| Postoperative Q-value | 11 | 1655 | MD −0.42 (−0.64, −0.21) | .000 | 98.4% |
| ≧100 | 6 | 1292 | MD −0.46 (−0.73, −0.18) | .001 | 98.9% |
| <100 | 5 | 363 | MD −0.38 (−0.83, 0.06) | .093 | 97.9% |
| Postoperative refractive SE | 6 | 1627 | MD 0.08 (−0.09, 0.25) | .336 | 95.4% |
| ≧100 | 5 | 1543 | MD 0.11 (−0.11, 0.33) | .315 | 96.3% |
| <100 | 1 | 84 | MD −0.02 (−0.10, 0.06) | .621 | / |
| HOA | 10 | 1309 | MD −0.14 (−0.23, −0.06) | .001 | 98.5% |
| ≧100 | 3 | 813 | MD −0.18 (−0.40, 0.04) | .109 | 99.6% |
| <100 | 7 | 496 | MD −0.12 (−0.20, −0.05) | .001 | 94.6% |
| Horizontal coma-like aberration | 5 | 404 | MD −0.00 (−0.03, 0.03) | .966 | 0.0% |
| ≧100 | 1 | 128 | MD 0.00 (−0.05, 0.06) | .880 | / |
| <100 | 4 | 276 | MD −0.00 (−0.05, 0.04) | .851 | 0.0% |
| Vertical coma-like aberration | 6 | 455 | MD −0.01 (−0.03, 0.01) | .263 | 0.0% |
| ≧100 | 1 | 128 | MD −0.00 (−0.05, 0.04) | .814 | / |
| <100 | 5 | 327 | MD −0.01 (−0.04, 0.01) | .253 | 0.0% |
| Spherical-like aberration | 12 | 1305 | MD −0.19 (−0.32, −0.06) | .004 | 99.2% |
| ≧100 | 5 | 809 | MD −0.36 (−0.64, −0.08) | .011 | 99.6% |
| <100 | 7 | 496 | MD −0.08 (−0.20, 0.05) | .238 | 98.6% |